Streetbeat News

Analyst Ratings

MREO

Needham analyst Gil Blum has reiterated a 'Buy' rating on Mereo BioPharma Group (NASDAQ:MREO) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:21 am

CDTX

Needham analyst Joseph Stringer has reiterated a 'Buy' rating on Cidara Therapeutics (NASDAQ:CDTX) and maintained a price target of $3.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:17 am

GIII

Keybanc analyst Noah Zatzkin maintains an Overweight rating on G-III Apparel Group (NASDAQ:GIII) and raises the price target from $23 to $26.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:16 am

KR

Kroger Co. (NYSE:KR) is set to report its Q2 2023 financial results on Sept. 8, 2023. Analysts predict earnings of 91 cents per share, up from 90 cents per share a year ago, and revenue of $34.12 billion, down from $34.64 billion. Kroger shares gained 1% in after-hours trading. Analysts from Morgan Stanley, Northcoast Research, Deutsche Bank, JP Morgan, and Wells Fargo have recently revised their ratings and price targets for the company.

Portfolio Pulse from Lisa Levin

September 08, 2023 | 7:04 am

RENT

Rent the Runway, Inc. (NASDAQ:RENT) is expected to report a narrower Q2 2023 loss of 43 cents per share, compared to a loss of 53 cents per share in the same period last year. The company's revenue is projected to be $78.25 million, slightly up from $76.5 million in the year-ago period. The company's shares gained 3.7% to $1.41 in the after-hours trading session. Analysts from Piper Sandler, Barclays, Goldman Sachs, and Credit Suisse have recently updated their ratings and price targets for the company.

Portfolio Pulse from Lisa Levin

September 08, 2023 | 5:58 am

BAM

Brookfield Asset Mgmt (NYSE:BAM) has received two somewhat bullish and two indifferent ratings from analysts in the last quarter. The average 12-month price target for the company has increased by 21.21% from $33.00 to $40.00.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 9:00 pm

C

In the last quarter, Citigroup (NYSE:C) received 1 bullish, 6 somewhat bullish, 3 indifferent, and 3 somewhat bearish ratings from 13 analysts. The average 12-month price target for the company is $55.81, down 8.18% from the previous average of $60.78.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 9:00 pm

TFC

Over the last quarter, Truist Finl (NYSE:TFC) has received various analyst ratings, with 2 bullish, 3 somewhat bullish, and 7 indifferent. The company's average 12-month price target is $38.5, a decrease of 7.36% from the previous average of $41.56.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 9:00 pm

HRMY

Harmony Biosciences (NASDAQ:HRMY) has received 9 analyst ratings in the last quarter, with 6 being bullish, 3 somewhat bullish, and none being bearish or indifferent. The average 12-month price target for the company is $63.67, a decrease of 3.05% from the previous average of $65.67.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 9:00 pm

JBL

Analysts have given Jabil (NYSE:JBL) positive ratings in the last quarter, with an average price target of $116.67, indicating an upside from the current price of $108.65. This average has increased by 21.28% from the previous average price target of $96.20.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 9:00 pm